Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Shimada

Showing results (671-680 of 769) with videos related to

Pageof 77
Sort By:
Cancer|November 6, 2003
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodularMichel Peuchmaur, Emanuele S G d'Amore, Vijay V Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.
The American Journal of Pathology|January 17, 2009
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupElai Davicioni, Michael J Anderson, Friedrich Graf Finckenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology GroupJohn A van Doorninck, Lingyun Ji, Betty Schaub, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2016
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group databaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Cell Death & Disease|May 16, 2020
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastomaSung-Jen Wei, Thinh H Nguyen, In-Hyoung Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 10, 2017
Age-dependent changes in physical performance and body composition in community-dwelling Japanese older adultsHyuma Makizako, Hiroyuki Shimada, Takehiko Doi, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort surveyJustina L Groeger, Emmeline Ayers, Nir Barzilai, et al.
EMBO Molecular Medicine|October 15, 2016
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortalityLin Li, Xiaotian Qi, Weili Sun, et al.
Pageof 77

Showing results (671-680 of 769) with videos related to

Sort By:
Pageof 77
Cancer|November 6, 2003
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodularMichel Peuchmaur, Emanuele S G d'Amore, Vijay V Joshi, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2011
Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG projectPaola Angelini, Wendy B London, Susan L Cohn, et al.
The American Journal of Pathology|January 17, 2009
Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology GroupElai Davicioni, Michael J Anderson, Friedrich Graf Finckenstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 24, 2010
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology GroupJohn A van Doorninck, Lingyun Ji, Betty Schaub, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2016
Prognostic significance of pattern and burden of metastatic disease in patients with stage 4 neuroblastoma: A study from the International Neuroblastoma Risk Group databaseDaniel A Morgenstern, Wendy B London, Derek Stephens, et al.
Cell Death & Disease|May 16, 2020
MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastomaSung-Jen Wei, Thinh H Nguyen, In-Hyoung Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2010
Ewing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology GroupAaron Cooper, John van Doorninck, Lingyun Ji, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 10, 2017
Age-dependent changes in physical performance and body composition in community-dwelling Japanese older adultsHyuma Makizako, Hiroyuki Shimada, Takehiko Doi, et al.
Cerebral Circulation - Cognition and Behavior|November 3, 2022
Inflammatory biomarkers and motoric cognitive risk syndrome: Multicohort surveyJustina L Groeger, Emmeline Ayers, Nir Barzilai, et al.
EMBO Molecular Medicine|October 15, 2016
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortalityLin Li, Xiaotian Qi, Weili Sun, et al.
Pageof 77